Differences in PD-L1 Expression between oral and oropharyngeal squamous cell carcinoma

Treatment of metastasized or recurrent oral (OSCC) and oropharyngeal (OPSCC) squamous cell carcinoma remains challenging. Targeted antibody-based therapy inter alia for PD-1 / PD-L1 axis shows promising results, but whether PD-L1 expression varies between the subentities remains unclear. The express...

Descripción completa

Detalles Bibliográficos
Autores principales: Blatt, Sebastian, Krüger, Maximilian, Rump, Constantin, Zimmer, Stefanie, Sagheb, Keyvan, Künzel, Julian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140279/
https://www.ncbi.nlm.nih.gov/pubmed/35622885
http://dx.doi.org/10.1371/journal.pone.0269136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140279/
https://www.ncbi.nlm.nih.gov/pubmed/35622885
http://dx.doi.org/10.1371/journal.pone.0269136

Ejemplares similares